Sharma Rajani, Roy Abhik, Ramos Christopher, Rosenberg Richard, Garcia-Carrasquillo Reuben, Lebwohl Benjamin
Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, New York, NY, USA.
Division of Digestive and Liver Diseases, Department of Medicine, Columbia University Medical Center, 180 Fort Washington Avenue, Suite 936, New York, NY 10032, USA.
Therap Adv Gastroenterol. 2017 May;10(5):387-396. doi: 10.1177/1756283X17694807. Epub 2017 Mar 26.
Aspirin, when used with concurrent anticoagulation, increases the risk of gastrointestinal bleeding (GIB). Therefore, multisociety guidelines recommend prophylactic proton-pump inhibitors (PPIs) for patients receiving aspirin and anticoagulation. We aimed to determine rates and predictors of adherence to these recommendations.
All adult inpatients discharged from the hospital on aspirin and anticoagulation from July 2009 to June 2014 were retrospectively evaluated for PPI prescription on discharge instructions. We used univariate and multivariate logistic regression to test for predictors of PPI prescription.
A total of 2422 patients were discharged on aspirin and anticoagulation; the mean age was 68 years and 53.2% were male; 42.2% were prescribed a PPI at discharge. On univariate analysis, factors associated with discharge PPI prescription included increased age (47.1% 37.9%), white race (47.3% 37.1-40.2%), higher aspirin dose (55.1% 39.4%), being married (46.2% 39.4%) and preadmission PPI use (96.6% 23.4%). On multivariate analysis, significant predictors of discharge PPI prescription were age 60-69 years [odds ratio (OR) 1.61] and 70-79 years (OR 1.48), and preadmission PPI use (OR 120.03). Lower odds of discharge PPI prescription included Medicaid (OR 0.55) or Medicare (OR 0.71) insurance, Spanish language (OR 0.63), and lower dose aspirin (81 mg) (OR 0.40).
A total of 42.2% of patients discharged on aspirin and anticoagulation were prescribed PPIs. Older age and preadmission PPI use were predictive of PPI prescription, while Medicaid/Medicare insurance, Spanish language, and lower dose aspirin decreased the likelihood of discharge PPI prescription. This creates an opportunity to improve primary GIB prevention through quality improvement interventions.
阿司匹林与抗凝药同时使用时,会增加胃肠道出血(GIB)的风险。因此,多个学会的指南建议为接受阿司匹林和抗凝治疗的患者使用预防性质子泵抑制剂(PPI)。我们旨在确定遵循这些建议的比例及预测因素。
对2009年7月至2014年6月期间从医院出院的所有服用阿司匹林并接受抗凝治疗的成年住院患者进行回顾性评估,以确定出院医嘱中是否开具了PPI。我们使用单因素和多因素逻辑回归来检验PPI处方的预测因素。
共有2422例患者出院时服用阿司匹林并接受抗凝治疗;平均年龄为68岁,53.2%为男性;42.2%的患者出院时开具了PPI。单因素分析显示,与出院时开具PPI相关的因素包括年龄增加(47.1%对37.9%)、白人种族(47.3%对37.1%-40.2%)、阿司匹林剂量较高(55.1%对39.4%)、已婚(46.2%对39.4%)以及入院前使用PPI(96.6%对23.4%)。多因素分析显示,出院时开具PPI的显著预测因素为年龄60-69岁[比值比(OR)1.61]和70-79岁(OR 1.48),以及入院前使用PPI(OR 120.03)。出院时开具PPI的可能性较低的因素包括医疗补助(OR 0.55)或医疗保险(OR 0.71)参保、西班牙语(OR 0.63)以及低剂量阿司匹林(81毫克)(OR 0.40)。
共有42.2%出院时服用阿司匹林并接受抗凝治疗的患者开具了PPI。年龄较大和入院前使用PPI可预测PPI处方,而医疗补助/医疗保险参保、西班牙语以及低剂量阿司匹林则降低了出院时开具PPI的可能性。这为通过质量改进干预措施改善原发性GIB预防创造了机会。